150 related articles for article (PubMed ID: 36865008)
21. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
Timlin H; Lee SM; Manno RL; Seo P; Geetha D
Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
[TBL] [Abstract][Full Text] [Related]
22. Management of severe renal disease in anti-neutrophil-cytoplasmic-antibody-associated vasculitis: the place of rituximab and plasma exchange?
Morel P; Karras A; Porcher R; Belenfant X; Audard V; Rafat C; Hanouna G; Beaudreuil S; Vilain C; Hummel A; Terrier B; Pillebout E; Groh M; Jouenne R; Dhote R; Fain O; Ponsoye M; Noel N; Limal N; Puéchal X; Le Jeunne C; Guillevin L; Mouthon L; Régent A
Rheumatology (Oxford); 2022 Oct; 61(10):4056-4064. PubMed ID: 35108368
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis.
Tampe D; Korsten P; Ströbel P; Hakroush S; Tampe B
Front Immunol; 2021; 12():736638. PubMed ID: 34630417
[TBL] [Abstract][Full Text] [Related]
24. Assessment of Renal Risk Score and Histopathological Classification for Prediction of End-Stage Kidney Disease and Factors Associated With Change in eGFR After ANCA-Glomerulonephritis Diagnosis.
Brilland B; Boud'hors C; Copin MC; Jourdain P; Henry N; Wacrenier S; Djema A; Samoreau C; Coindre JP; Cousin M; Riou J; Croue A; Saint-André JP; Subra JF; Piccoli GB; Augusto JF
Front Immunol; 2022; 13():834878. PubMed ID: 35392077
[TBL] [Abstract][Full Text] [Related]
25. Immunosuppressive agents for treating IgA nephropathy.
Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
[TBL] [Abstract][Full Text] [Related]
26. Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis.
Jarrot PA; Chiche L; Hervier B; Daniel L; Vuiblet V; Bardin N; Bertin D; Terrier B; Amoura Z; Andrés E; Rondeau E; Hamidou M; Pennaforte JL; Halfon P; Daugas E; Dussol B; Puéchal X; Kaplanski G; Jourde-Chiche N
Medicine (Baltimore); 2016 May; 95(22):e3748. PubMed ID: 27258503
[TBL] [Abstract][Full Text] [Related]
27. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
von Groote TC; Williams G; Au EH; Chen Y; Mathew AT; Hodson EM; Tunnicliffe DJ
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004293. PubMed ID: 34778952
[TBL] [Abstract][Full Text] [Related]
28. Rituximab for remission induction in recurrent ANCA-associated glomerulonephritis postkidney transplant.
Murakami C; Manoharan P; Carter-Monroe N; Geetha D
Transpl Int; 2013 Dec; 26(12):1225-31. PubMed ID: 24118474
[TBL] [Abstract][Full Text] [Related]
29. Rapidly progressive crescentic glomerulonephritis: Early treatment is a must.
Moroni G; Ponticelli C
Autoimmun Rev; 2014 Jul; 13(7):723-9. PubMed ID: 24657897
[TBL] [Abstract][Full Text] [Related]
30. The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis.
Walsh M; Collister D; Zeng L; Merkel PA; Pusey CD; Guyatt G; Au Peh C; Szpirt W; Ito-Hara T; Jayne DRW;
BMJ; 2022 Feb; 376():e064604. PubMed ID: 35217545
[TBL] [Abstract][Full Text] [Related]
31. Metabolic Syndrome Severity Score, Comparable to Serum Creatinine, Could Predict the Occurrence of End-Stage Kidney Disease in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Park PG; Pyo JY; Ahn SS; Song JJ; Park YB; Huh JH; Lee SW
J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945043
[TBL] [Abstract][Full Text] [Related]
32. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.
Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P
Front Immunol; 2021; 12():625672. PubMed ID: 33841408
[TBL] [Abstract][Full Text] [Related]
33. Histopathological prognostic factors in ANCA-associated glomerulonephritis.
Boud'hors C; Copin MC; Wacrenier S; Piccoli GB; Croue A; Augusto JF; Brilland B
Autoimmun Rev; 2022 Sep; 21(9):103139. PubMed ID: 35835443
[TBL] [Abstract][Full Text] [Related]
34. Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis.
Casal Moura M; Fervenza FC; Specks U; Sethi S
Nephrol Dial Transplant; 2022 Aug; 37(9):1710-1721. PubMed ID: 34436585
[TBL] [Abstract][Full Text] [Related]
35. [Kidney injury molecules (KIM-1, MCP-1) and type IV collagen in the assessment of activity of antineutrophil cytoplasmic antibody-associated glomerulonephritis].
Bulanov NM; Serova AG; Kuznetsova EI; Bulanova ML; Novikov PI; Kozlovskaya LV; Moiseev SV
Ter Arkh; 2017; 89(6):48-55. PubMed ID: 28745689
[TBL] [Abstract][Full Text] [Related]
36. Lymphopaenia at diagnosis of anti-neutrophil cytoplasmic antibody-vasculitis with renal involvement is correlated with severity and renal prognosis.
Wacrenier S; Riou J; Jourdain P; Guibert F; Henry N; Djema A; Coindre JP; Crochette R; Cousin M; Croue A; Subra JF; Piccoli G; Augusto JF; Brilland B
Nephrol Dial Transplant; 2022 May; 37(6):1078-1087. PubMed ID: 33856482
[TBL] [Abstract][Full Text] [Related]
37. [State of art and new perspectives in the induction regimen of ANCA-associated vasculitis with renal involvement: from histopathology to therapy].
Uzzo M; Alberici F
G Ital Nefrol; 2021 Feb; 38(1):. PubMed ID: 33599423
[TBL] [Abstract][Full Text] [Related]
38. Urinary Matrix Metalloproteinase 7 Activated by Oxidative Stress Predicts Kidney Prognosis in Myeloperoxidase-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Wu L; Wang G; Yang B; Liu X; Xie C; Feng X; Jin L; Zhou Z; Yang M; Zhou Z; Su C; Li Y; Song Y; Cao W
Antioxid Redox Signal; 2022 Aug; 37(4-6):246-256. PubMed ID: 35152729
[No Abstract] [Full Text] [Related]
39. Rituximab for treatment of severe renal disease in ANCA associated vasculitis.
Geetha D; Hruskova Z; Segelmark M; Hogan J; Morgan MD; Cavero T; Eriksson P; Seo P; Manno RL; Dale J; Harper L; Tesar V; Jayne DR
J Nephrol; 2016 Apr; 29(2):195-201. PubMed ID: 25986390
[TBL] [Abstract][Full Text] [Related]
40. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
